Skip to main content
OpenTrials

Clinical trial condition

Immunoglobulin Light-chain Amyloidosis

Explore clinical trials studying Immunoglobulin Light-chain Amyloidosis. Study availability and eligibility vary by location and protocol.

182 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Immunoglobulin Light-chain Amyloidosis trial results

Completed

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

NCT00112593

Conditions
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +281 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed

NCT01194791

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations
  • Hospital Universitario de Canarias Santa Cruz de Tenerife, Canary Islands, Spain
  • Hospital Germans Trias i Pujol Badalona, Spain
  • Hospital Clínic Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
View Trial Details
Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 326 locations
View Trial Details

Related conditions